NEW YORK - Investeringsmaatschappij KKR & Co. Inc. (NYSE: KKR) heeft een meerderheidsbelang verworven in HealthCare Royalty Partners (HCRx), een bedrijf gespecialiseerd in biofarmaceutische ...

KKR has acquired a majority stake in HealthCare Royalty Partners, pushing the investment firm further into the healthcare ...

KKR & Co. Inc., a leading global investment firm, today announced that it has acquired a majority ownership stake in HealthCare Royalty Partners (HCRx), a leading biopharma royalty acquisition company ...

As part of the transaction, HCRx Chairman and CEO Clarke Futch will continue to lead the HCRx team and will maintain an ongoing substantial minority interest in HCRx.

Investment firm KKR (KKR) announced on Wednesday the acquisition of a majority stake in the biopharma royalty acquisition company, HealthCare Royalty Partners.

KKR executives said strong momentum in their business gave them confidence on Thursday of beating earnings targets for 2026, ...

Investment giant KKR reported a 9% rise in adjusted net income for the second quarter on Thursday, bolstered by an increase ...

Inside KKR's bold $1 trillion playbook: data centers, Harley deals, and the biggest credit fund in its history.

Detailed price information for KKR & Company LP (KKR-N) from The Globe and Mail including charting and trades.

Ajax Health's announcement of the creation of FlowMod in collaboration with KKR (NYSE:KKR) marked a significant strategic alliance aimed at addressing heart failure. Despite such forward-looking ...

KKR (KKR), searching for takeover targets amid volatile markets, is exploring a potential purchase of GPI SpA, an Italian healthcare technology firm, according to a media report on Wednesday.